Test Can ID Patients at Risk for Severe COVID-19, Study Suggests

Test Can ID Patients at Risk for Severe COVID-19, Study Suggests

A genomic test being developed by a Charlottesville company can predict a patient’s risk of developing severe COVID-19, new research from UVA Health suggests. That information could help doctors identify patients at high risk for poor outcomes and quickly begin tailored treatment. 

read more
New Breakthrough Test Detects and Predicts Severity of COVID-19

New Breakthrough Test Detects and Predicts Severity of COVID-19

AMPEL BioSolutions today announced a breakthrough in precision and personalized medicine that can detect and predict the severity of COVID-19 in patients while also determining the best treatment options for each specific case. The company’s new approach, through a simple blood test, will ultimately accelerate the means of providing effective treatments to the right people at the right time and potentially stem the serious illness caused by SARS-CoV-2 infection that can lead to lung damage or death.

read more
New test may guide treatment of common skin diseases

New test may guide treatment of common skin diseases

Dermatologists routinely do skin biopsies to figure out what’s wrong with their patients. They study tissue under a microscope – looking at the structure of cells, but a Charlottesville company says doctors could treat disease more precisely by looking at genetics.

read more

Pin It on Pinterest